Arvelle is a startup based in Germany, most recent round Acquired, 2 tracked investors.
Based in Germany, Arvelle is a startup. Arvelle has been acquired. Brouky records 2 investors associated with the company.
A biopharmaceutical company focused on developing and commercializing cenobamate, an investigational antiepileptic drug, in the European market.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.